Colombia vs Togo: Cause of death, by non-communicable diseases, ages 60+, female
Colombia
71.4%
in 2021
Togo
71.5%
in 2021
Colombia rank
110th
Togo rank
109th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Colombia
- Togo
How they compare
Togo currently reports 71.5% against 71.4% in Colombia, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Colombia ahead.
Colombia ranks 110th and Togo ranks 109th of 185 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.1% | 69.3% | 21.8% | Colombia |
| 2010s | 90.8% | 73.3% | 17.5% | Colombia |
| 2020s | 74.5% | 72.8% | 1.6% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Colombia or Togo?
- Togo, at 71.5% against 71.4% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Colombia and Togo?
- 0.1%, with Togo ahead.
- How many years of comparable data are there for Colombia and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Togo rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Colombia ranks 110th and Togo ranks 109th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.